← Browse by Condition
Medical Condition
generalized myasthenia gravis
Total Trials
5
Recruiting Now
5
Trial Phases
Phase 1, Phase 2, Phase 2, Phase 3
NCT06704269 Phase 1, Phase 2
Recruiting
Study to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Generalized Myasthenia Gravis
Enrollment
15 pts
Location
United States, Franc...
Sponsor
Novartis Pharmaceuticals
NCT06193889 Phase 2, Phase 3
Recruiting
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
Enrollment
66 pts
Location
United States, Brazi...
Sponsor
Kyverna Therapeutics
NCT06064695
Recruiting
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Myasthenia Gravis
Enrollment
16 pts
Location
United States
Sponsor
University of Missouri-Columbi...
NCT07294170
Recruiting
ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
Enrollment
70 pts
Location
United States
Sponsor
argenx
NCT04833894 Phase 2, Phase 3
Recruiting
Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intravenously in Children With Generalized Myasthenia Gravis
Enrollment
12 pts
Location
United States, Austr...
Sponsor
argenx